![Peter Svennilson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Svennilson
Fondateur chez
The Column Group LLC
Fortune : 873 231 $ au 31/05/2026
Profil
Peter Svennilson was the founder of Three Crowns Capital Bermuda Ltd., founded in 1996, where the title held was Managing Partner from 1996 to 2006.
Mr. Svennilson is the founder of The Column Group LLC, founded in 2007, holding the title of Managing Partner since 2011.
Current jobs include Independent Director at Carmot Therapeutics, Inc. since 2020, Director at Circle Pharma, Inc. since 2020, Director at Ribon Therapeutics, Inc. since 2017, Trustee at Institute for Advanced Study, and Managing Partner at TCG Labs-Soleil.
Former jobs include Chairman at Aragon Pharmaceuticals, Inc. from 2009 to 2013, Chairman at Seragon Pharmaceuticals, Inc. from 2013 to 2014, Associate Managing Director at Nomura International Plc, Director at Rosetta Inpharmatics LLC from 1996 to 2006, Associate Managing Director at European Investment Bank, Director at Tercica, Inc., Director at PTC Therapeutics, Inc. from 2012 to 2014, Director at ChemoCentryx, Inc., Independent Director at NGM Biopharmaceuticals, Inc. from 2008 to 2020, Director at SomaLogic Operating Co., Inc., Independent Director at Constellation Pharmaceuticals, Inc. from 2016 to 2019, Independent Director at Immune Design Corp.
from 2013 to 2018, Independent Director at Revolution Medicines, Inc. from 2020 to 2021, Independent Director at Gritstone bio, Inc. from 2015 to 2019, Independent Director at Oric Pharmaceuticals, Inc. from 2015 to 2021, and Independent Director at Rapt Therapeutics, Inc. from 2020 to 2021.
Education includes an MBA degree from Stockholm School of Economics, conferred in 1985.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/09/2025 | 103 341 ( 0,1 % ) | 873 231 $ | 31/05/2026 |
Postes actifs de Peter Svennilson
| Sociétés | Poste | Début |
|---|---|---|
The Column Group LLC
 The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Fondateur | 21/09/2010 |
Institute for Advanced Study, Inc.
 Institute for Advanced Study, Inc. Miscellaneous Commercial ServicesCommercial Services Provides theoretical research and intellectual inquiry services | Directeur/Membre du Conseil | - |
Ribon Therapeutics, Inc.
 Ribon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops cacner therapies | Directeur/Membre du Conseil | 01/01/2017 |
Circle Pharma, Inc.
 Circle Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Directeur/Membre du Conseil | 20/03/2020 |
Carmot Therapeutics, Inc.
 Carmot Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops drugs for inflammatory, metabolic and neurological diseases | Directeur/Membre du Conseil | 01/03/2020 |
Anciens postes connus de Peter Svennilson
| Sociétés | Poste | Fin |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Directeur Général | 01/11/2015 |
| RAPT THERAPEUTICS, INC. | Directeur/Membre du Conseil | 30/06/2021 |
| REVOLUTION MEDICINES, INC. | Directeur/Membre du Conseil | 22/06/2021 |
| NGM BIOPHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/05/2020 |
| ░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Peter Svennilson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
23
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 23 |
|---|---|
Nomura International Plc
 Nomura International Plc Investment Banks/BrokersFinance Provides brokerage services | Finance |
Rosetta Inpharmatics LLC
 Rosetta Inpharmatics LLC BiotechnologyHealth Technology Develops and implements drug discovery technology | Health Technology |
European Investment Bank
 European Investment Bank General GovernmentGovernment Operates as a multilateral financial institution which offers loans, guarantees, equity investments and advisory services | Government |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Health Technology |
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Three Crowns Capital Bermuda Ltd. | |
NGM Biopharmaceuticals, Inc.
 NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
Stockholm School of Economics
 Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SomaLogic Operating Co., Inc.
 SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology Operates as a protein biomarker discovery and clinical diagnostics company | Health Technology |
Institute for Advanced Study, Inc.
Institute for Advanced Study, Inc. Miscellaneous Commercial ServicesCommercial Services Provides theoretical research and intellectual inquiry services | Commercial Services |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs targeting regulators of epigenetic function | Health Technology |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Carmot Therapeutics, Inc.
Carmot Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops drugs for inflammatory, metabolic and neurological diseases | Health Technology |
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer | Health Technology |
Circle Pharma, Inc.
Circle Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Revolution Medicines, Inc.
 Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
Gritstone bio, Inc.
 Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
Oric Pharmaceuticals, Inc.
 Oric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceutical products | Health Technology |
Ribon Therapeutics, Inc.
Ribon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops cacner therapies | Health Technology |
Rapt Therapeutics, Inc.
 Rapt Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oral small molecule therapies for patients | Health Technology |
